📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Characterization of dominant-negative growth hormone receptor variants reveals a potential therapeutic target for short stature. (2023)

First Author: Andrews A

Attributed to: Child Growth and development funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ejendo/lvad039

PubMed Identifier: 36943306

Publication URI: http://europepmc.org/abstract/MED/36943306

Type: Journal Article/Review

Volume: 188

Parent Publication: European journal of endocrinology

Issue: 4

ISSN: 0804-4643